Status:
COMPLETED
The Heart Hive COVID-19 Study
Lead Sponsor:
Imperial College London
Conditions:
COVID-19
Cardiomyopathies
Eligibility:
All Genders
18+ years
Brief Summary
All patients with heart disease should have the opportunity to participate in research into their condition, to advance knowledge and treatment. The HeartHive COVID-19 study is an international onlin...
Detailed Description
The impact of the COVID-19 pandemic on patients with cardiomyopathy has not been explored and represents a critical unmet need. Insights into exposure, healthcare outcomes, behavioural changes and the...
Eligibility Criteria
Inclusion
- Adult (age 18 and over) Males or Females
- Capacity to provide informed consent
- Subjects with either:
- A self-reported confirmed diagnosis of cardiomyopathy (dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy) Or
- No self-reported history of heart disease
- Note: Pregnant women are eligible. This study is observational and entirely separate from clinical care.
Exclusion
- \- Patients who lack capacity to consent for themselves Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill)
- \- Although usually considered a vulnerable group, pregnant women are eligible for this study which is observational and entirely separate from clinical care.
- Patients with a confirmed history of coronary artery disease:
- who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or
- who have undergone previous percutaneous coronary intervention or coronary bypass surgery History of primary valvular heart disease or congenital heart disease Severe, untreated or untreatable hypertension (systolic blood pressures routinely \>180 mm Hg and/or diastolic blood pressures \>120 mm Hg)
Key Trial Info
Start Date :
July 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 21 2022
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT04468256
Start Date
July 26 2020
End Date
July 21 2022
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College London
London, United Kingdom, W12 0NN